Product image of Isturisa 1mg (Osilodrostat) 1mg Tablet supplied by GNH India

Isturisa 1mg

Active Ingredient:
Osilodrostat
Form:
Tablet
Brand:
Isturisa
Origin:
Switzerland

Isturisa 1mg (Osilodrostat Tablet) 1mg

Osilodrostat, the active ingredient in Isturisa 1mg, is a steroidogenesis inhibitor presented as a 1mg tablet for oral use. It is used to treat Cushing's disease and Cushing's syndrome in adults. GNH India supplies Isturisa 1mg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Isturisa 1mg is a specialized medication designed to manage conditions related to excessive cortisol production. It is part of a broader therapeutic approach to endocrinological disorders, particularly those affecting the adrenal glands.

Strength

1mg

Pack Size

60s

Storage

Ambient

Manufacturer / TM Owner

Recordati Rare Diseases

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Isturisa 1mg is primarily used to manage conditions associated with excessive cortisol production. It is indicated for the treatment of Cushing's disease and Cushing's syndrome in adults. The medication helps to reduce the symptoms associated with these conditions by lowering cortisol levels in the body.

  • Cushing's disease: Reduces cortisol levels to alleviate symptoms such as weight gain, moon face, and fatigue.
  • Cushing's syndrome: Helps manage symptoms caused by prolonged exposure to high cortisol levels, including hypertension and glucose intolerance.
  • Endogenous hypercorticism: Treats conditions where the body produces too much cortisol, leading to various metabolic and hormonal imbalances.

How It Works

  • Isturisa 1mg works by inhibiting the enzyme 11β-hydroxylase (CYP11B1), which is responsible for the final step in cortisol synthesis in the adrenal glands. By blocking this enzyme, osilodrostat reduces the production of cortisol, thereby alleviating the symptoms associated with Cushing's disease and Cushing's syndrome. This mechanism helps to restore normal hormonal balance in the body.

Side Effects

Isturisa 1mg may cause various side effects, ranging from common to serious. It is important to monitor patients closely for any adverse reactions.

Common Side Effects

  • Diarrhea: Frequent loose stools or abdominal discomfort.
  • Nausea: Feeling sick to the stomach, sometimes leading to vomiting.
  • Fatigue: Persistent tiredness or lack of energy.
  • Headache: Pain or discomfort in the head.
  • Abdominal pain: Discomfort or cramping in the stomach area.
  • Dizziness: Feeling lightheaded or unsteady.
  • Hypokalemia: Low potassium levels in the blood, which can cause muscle weakness and irregular heartbeats.
  • Hypocortisolism: Insufficient cortisol production, leading to symptoms such as fatigue, weakness, and low blood pressure.

Serious or Rare Side Effects

  • Hypotension: Abnormally low blood pressure, which can cause dizziness or fainting.
  • QT prolongation: A heart rhythm disorder that can increase the risk of sudden cardiac arrest.
  • Liver enzyme elevation: Increased levels of liver enzymes, indicating potential liver damage.
  • Syncope: Temporary loss of consciousness, often due to a drop in blood pressure.
  • Allergic reactions: Severe allergic responses, including rash, itching, and swelling.

Precautions & Warnings

Isturisa 1mg should be used with caution and under the supervision of a healthcare professional. Certain precautions and warnings should be observed to ensure safe and effective use.

  • Monitoring: Regular monitoring of cortisol levels and adrenal function is essential to adjust the dosage and avoid complications.
  • Pregnancy: Use during pregnancy should be carefully considered, and the treatment should be stopped at least one week before planned conception.
  • Breastfeeding: Avoid breastfeeding while taking Isturisa 1mg, as the effects on the infant are not well understood.
  • QT prolongation: Patients with a history of heart conditions or those taking medications that prolong the QT interval should be monitored closely.
  • Hypocortisolism: Be aware of the symptoms of hypocortisolism, such as fatigue, weakness, and low blood pressure, and seek medical attention if they occur.
  • Store below 25°C: Keep in the original pack, protect from moisture.

Avoid Interactions

Isturisa 1mg may interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. It is important to be aware of these interactions.

Major Interactions (Avoid)

  • CYP3A inhibitors: Medications that inhibit the CYP3A enzyme can increase the levels of osilodrostat in the body, leading to an increased risk of side effects.
  • CYP3A inducers: Medications that induce the CYP3A enzyme can decrease the levels of osilodrostat, reducing its effectiveness.
  • Corticosteroids: Concurrent use with corticosteroids can interfere with the therapeutic effects of Isturisa 1mg.
  • Drugs that prolong QT interval: Combining Isturisa 1mg with medications that prolong the QT interval can increase the risk of serious heart rhythm disorders.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: Isturisa 1mg may lower blood pressure, and concurrent use with antihypertensive medications can increase the risk of hypotension.
  • Diuretics: Diuretics can lower potassium levels, which can be exacerbated by Isturisa 1mg, leading to hypokalemia.
  • Antidiabetic medications: Isturisa 1mg can affect glucose metabolism, and concurrent use with antidiabetic medications may require dosage adjustments.

Frequently Asked Questions

Isturisa 1mg is used to treat Cushing's disease and Cushing's syndrome in adults. It helps to reduce the symptoms associated with these conditions by lowering cortisol levels in the body. The medication is specifically designed to manage conditions related to excessive cortisol production, which can lead to various metabolic and hormonal imbalances.

Osilodrostat, the active ingredient in Isturisa 1mg, works by inhibiting the enzyme 11β-hydroxylase (CYP11B1). This enzyme is responsible for the final step in cortisol synthesis in the adrenal glands. By blocking this enzyme, osilodrostat reduces the production of cortisol, thereby alleviating the symptoms associated with Cushing's disease and Cushing's syndrome.

The usual starting dose of Isturisa 1mg is determined by a healthcare professional based on the patient's condition and response to the treatment. The dosage may be adjusted over time to achieve the desired therapeutic effect. It is important to follow the prescribed dosage and consult with a healthcare provider for any adjustments.

The use of Isturisa 1mg during pregnancy should be carefully considered, and the treatment should be stopped at least one week before planned conception. It is not recommended to breastfeed while taking Isturisa 1mg, as the effects on the infant are not well understood. Always consult with a healthcare provider for personalized advice.

To order Isturisa 1mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the import paperwork.

Isturisa 1mg is a specialized medication designed to manage Cushing's disease by inhibiting cortisol synthesis. Compared to other treatments, it offers a targeted approach to reducing cortisol levels. The choice of treatment depends on various factors, including the patient's specific condition, response to therapy, and potential side effects. Consult with a healthcare provider to determine the most suitable treatment option.

Isturisa 1mg should be stored below 25°C, in the original pack, and protected from moisture. It is important to keep the medication out of reach of children and to follow the storage instructions provided on the packaging. Proper storage ensures the effectiveness and safety of the medication.

Isturisa 1mg is administered orally, typically in the form of tablets. The dosage and administration schedule are determined by a healthcare professional based on the patient's condition and response to the treatment. It is important to follow the prescribed dosage and consult with a healthcare provider for any adjustments.

The most serious risks associated with Isturisa 1mg include QT prolongation, hypotension, and hypocortisolism. Patients should be monitored closely for any signs of these conditions, and any adverse reactions should be reported to a healthcare provider immediately. Regular monitoring of cortisol levels and adrenal function is essential to avoid complications.

Isturisa 1mg should not be used by individuals who are allergic to osilodrostat or any of the excipients in the medication. It should be used with caution in patients with a history of heart conditions, liver disease, or those taking medications that prolong the QT interval. Always consult with a healthcare provider to determine if Isturisa 1mg is suitable for you.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.